HomeAI · summaries
Storia in 2 fonti
Takeda says it expects to take $2.5B hit after Amitiza antitrust verdict, with plans to appeal
Takeda has updated its financial results to reflect costs it could incur after losing an antitrust lawsuit concerning its laxative drug Amitiza.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
A recent antitrust verdict has prompted Takeda to revise its 2025 financials, putting the drugmaker at a 152 billion Japanese yen ($949.37 million) loss for the fiscal year. |…
- ·
endpoints.news
Takeda says it expects to take $2.5B hit after Amitiza antitrust verdict, with plans to appeal
Takeda has updated its financial results to reflect costs it could incur after losing an antitrust lawsuit concerning its laxative drug Amitiza.